The Use of Immunotherapy in Triple-Negative Breast Cancer

被引：0

作者：

Schmid, Peter ^{[1
]}

机构：

[1] Queen Mary Univ London, Barts Canc Inst, Canc Med, London, England

来源：

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2021年 / 19卷 / 12期

关键词：

DOUBLE-BLIND; ATEZOLIZUMAB; PACLITAXEL;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：770 / 773

页数：4

共 8 条

[1]

Cortes J, 2021, ANN ONCOL, V32

[2]

Cortes J, 2020, LANCET, V396, P1817, DOI 10.1016/S0140-6736(20)32531-9

[3] First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis [J].

Emens, L. A. ;

Adams, S. ;

Barrios, C. H. ;

Dieras, V ;

Iwata, H. ;

Loi, S. ;

Rugo, H. S. ;

Schneeweiss, A. ;

Winer, E. P. ;

Patel, S. ;

Henschel, V ;

Swat, A. ;

Kaul, M. ;

Molinero, L. ;

Patel, S. ;

Chui, S. Y. ;

Schmid, P. .

ANNALS OF ONCOLOGY, 2021, 32 (08) :983-993

[4] Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer [J].

Miles, D. ;

Gligorov, J. ;

Andre, F. ;

Cameron, D. ;

Schneeweiss, A. ;

Barrios, C. ;

Xu, B. ;

Wardley, A. ;

Kaen, D. ;

Andrade, L. ;

Semiglazov, V ;

Reinisch, M. ;

Patel, S. ;

Patre, M. ;

Morales, L. ;

Patel, S. L. ;

Kaul, M. ;

Barata, T. ;

O'Shaughnessy, J. .

ANNALS OF ONCOLOGY, 2021, 32 (08) :994-1004

[5] Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial [J].

Mittendorf, Elizabeth A. ;

Zhang, Hong ;

Barrios, Carlos H. ;

Saji, Shigehira ;

Jung, Kyung Hae ;

Hegg, Roberto ;

Koehler, Andreas ;

Sohn, Joohyuk ;

Iwata, Hiroji ;

Telli, Melinda L. ;

Ferrario, Cristiano ;

Punie, Kevin ;

Penault-Llorca, Frederique ;

Patel, Shilpen ;

Anh Nguyen Duc ;

Liste-Hermoso, Mario ;

Maiya, Vidya ;

Molinero, Luciana ;

Chui, Stephen Y. ;

Harbeck, Nadia .

LANCET, 2020, 396 (10257) :1090-1100

[6]

Schmid PCJ., 2021, ANN ONCOL, V32

[7]

Schmid P, 2020, NEW ENGL J MED, V382, P810, DOI [10.1056/NEJMoa1910549, 10.1056/NEJMc2006684]

[8] Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Schmid, Peter ;

Rugo, Hope S. ;

Adams, Sylvia ;

Schneeweiss, Andreas ;

Barrios, Carlos H. ;

Iwata, Hiroji ;

Dieras, Veronique ;

Henschel, Volkmar ;

Molinero, Luciana ;

Chui, Stephen Y. ;

Maiya, Vidya ;

Husain, Amreen ;

Winer, Eric P. ;

Loi, Sherene ;

Emens, Leisha A. .

LANCET ONCOLOGY, 2020, 21 (01) :44-59

← 1 →